Work

YAP in MAPK pathway targeted therapy resistance

Year: 2015

Type: article

Abstract: Within the past several years, there have been major advances in cancer treatment through the use of molecularly targeted therapy, though resistance to therapy remains a significant issue. The clin...

Source: Cell Cycle

DOI: 10.1080/15384101.2015.1032644

Authors: Keith T Flaherty, Jennifer A Wargo, Trever G Bivona

Institutions: Massachusetts General Hospital, The University of Texas MD Anderson Cancer Center, University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center

Language: English

Topic: Melanoma and MAPK Pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: National Cancer Institute

Award: G1402578135

OpenAlex ID: W1749458517

FWCI: 0.517

Cites: 7

Cited by: 16

Related to: 10